Alzheimer’s Disease: The Way Forward

Alzheimer’s Disease: The Way Forward

Alzheimer’s Disease: The Way Forward Last week, we reviewed the pathology and genetics of Alzheimer’s disease (AD), and discussed the two most common AD drug development targets, amyloid-beta plaques and tau. This week, we’ll take a look at a variety of novel AD drug...